Pharmacological Basis for Use of a Novel Compound in Hyperuricemia: Anti-Hyperuricemic and Anti-Inflammatory Effects

por Lei Zhao, Yihang Li, Yihang Li, Dahong Yao, Dahong Yao, Ran Sun, Shifang Liu, Xi Chen, Xi Chen, Congcong Lin, Jian Huang, Jinhui Wang, Guang Li, Guang Li
Publicado 2021

Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer

por Leilei Fu, Shuya Wang, Xuan Wang, Peiqi Wang, Yaxin Zheng, Dahong Yao, Mingrui Guo, Lan Zhang, Liang Ouyang
Publicado 2016